(B)
Results of ASQ-3	Communication			Gross motor			Fine motor			Problem solving
	Normal	Borderline or suspect	P-value	Normal	Borderline or suspect	P-value	Normal	Borderline or suspect	P-value	Normal	Borderline or suspect	P-value
Clinical and paraclinical data
Minimal pre-ductal saturation (%)	82.1 ± 9.5	69.9 ± 14.2	0.001	79.9 ± 11.3	74.7 ± 14.7	0.23	80.9 ± 10.5	70.2 ± 14.7	0.008	78.9 ± 11.9	79.4 ± 13.4	0.90
Management and evolution data
Duration of intensive care stay (days)	11.2 ± 11.0	13.2 ± 16.4	0.54	11.1 ± 10.6	14.5 ± 19.3	0.73	9.8 ± 7.7	20.2 ± 23.5	0.14	11.0 ± 11.5	15.6 ± 17.9	0.38
Total length of hospital stay (days)	24.2 ± 18.5	26.2 ± 26.4	0.71	39.1 ± 64.8	97.2 ± 132.1	0.29	21.7 ± 15.2	38.1 ± 34.1	0.13	23.4 ± 19.2	32.3 ± 27.9	0.57
VISc	35.5 ± 66.0	91.0 ± 112.1	0.08	51.7 ± 70.2	161.9 ± 137.1	0.09	58.3 ± 79.2	115.2 ± 128.6	0.22	59.2 ± 86.7	110.9 ± 102.1	0.15
Dobutamine dosage (N = 22) (µg/kg/min)	9.4 ± 3.6	12.0 ± 3.9	0.09	9.3 ± 2.5	15.0 ± 5.8	0.04	9.8 ± 3.3	12.3 ± 5.2	0.32	9.4 ± 3.4	13.0 ± 4.0	0.02
Duration of Dobutamine (days)	1.0 ± 1.6	2.8 ± 3.0	0.03	1.3 ± 1.8	2.2 ± 3.3	0.65	1.2 ± 1.7	2.8 ± 3.4	0.17	1.2 ± 2.0	3.1 ± 2.5	0.015
Total duration of iNOd (days)	74.1 ± 54.9	118.9 ± 112.3	0.19	12.6 ± 5.4	11.8 ± 2.8	0.92	76.2 ± 56.5	127.5 ± 126.2	0.30	84.2 ± 75.6	93.0 ± 77.8	0.95
Total duration of mechanical ventilation (days)	163.6 ± 136.1	237.4 ± 303.9	0.28	170.1 ± 129.3	254.6 ± 363.2	0.81	155.7 ± 110.4	318.0 ± 369.1	0.06	180.0 ± 196.9	218.9 ± 173.2	0.29
Total duration of sedation (days)	5.4 ± 4.5	7.6 ± 8.1	0.32	5.7 ± 4.2	8.0 ± 9.8	0.91	5.0 ± 3.4	10.8 ± 9.9	0.02	5.8 ± 5.5	7.6 ± 6.4	0.35

NB, for quantitative variables with a normal distribution, student test otherwise Wilcoxon (Mann-Whitney). p is significant if p < 0.05.

^a WGA, weeks of gestational age.

^b MBP, mean blood pressure.

^c VIS, vasoactive-inotropic score.

^d iNO, inhaled nitric oxide.

Bold values indicate significant p-values < 0.05.